Search This Blog

Thursday, July 23, 2026

NovoCure posts narrower-than-expected Q2 loss, ups revenue guidance

 

NovoCure posts narrower-than-expected Q2 loss, revenue beats forecasts, raises 2026 revenue guidance to $710-$725 million

  • Q2 2026 net revenue was $184 million, representing 16% year-over-year growth
  • Company also increased full-year 2026 adjusted EBITDA guidance, alongside the higher revenue outlook
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)